Sign Out
Doxorubicin is used in the following indications: soft tissue and osteogenic sarcomas, Hodgkin's disease and non-Hodgkin's lymphoma, acute lymphoblastic leukaemia, acute myeloblastic leukaemia, carcinomas of the thyroid, breast, ovary, bladder, small cell bronchogenic carcinoma and neuroblastoma.
Some reports have shown that Doxorubicin may be used intravesically.
Benefits are evident in: multiple myeloma, endometrium carcinoma, carcinoma of the cervix, Wilms tumour, tumours of the head and neck, gastric cancer, cancer of pancreas, prostate, testicle and liver.
